Yin and Yang Part Deux: CCN5 inhibits the pro-fibrotic effects of CCN2

Item

http://www.wikidata.org/entity/Q42415902

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Yin and Yang Part Deux: CCN5 inhibits the pro-fibrotic effects of CCN2

@en

Yin and Yang Part Deux: CCN5 inhibits the pro-fibrotic effects of CCN2

@nl

type

Item

label

Yin and Yang Part Deux: CCN5 inhibits the pro-fibrotic effects of CCN2

@en

Yin and Yang Part Deux: CCN5 inhibits the pro-fibrotic effects of CCN2

@nl

prefLabel

Yin and Yang Part Deux: CCN5 inhibits the pro-fibrotic effects of CCN2

@en

Yin and Yang Part Deux: CCN5 inhibits the pro-fibrotic effects of CCN2

@nl

P1476

Yin and Yang Part Deux: CCN5 inhibits the pro-fibrotic effects of CCN2

@en

P2093

Andrew Leask

http://www.w3.org/2001/XMLSchema#string

P2860

The CCN family of proteins: structure-function relationships

Connective tissue growth factor (CCN2) induces adhesion of rat activated hepatic stellate cells by binding of its C-terminal domain to integrin alpha(v)beta(3) and heparan sulfate proteoglycan

All in the CCN family: essential matricellular signaling modulators emerge from the bunker

NOV (nephroblastoma overexpressed) and the CCN family of genes: structural and functional issues.

CCN3 (NOV) is a negative regulator of CCN2 (CTGF) and a novel endogenous inhibitor of the fibrotic pathway in an in vitro model of renal disease

Cooperative regulation of chondrocyte differentiation by CCN2 and CCN3 shown by a comprehensive analysis of the CCN family proteins in cartilage

Connective tissue growth factor is secreted through the Golgi and is degraded in the endosome

The opposing effects of CCN2 and CCN5 on the development of cardiac hypertrophy and fibrosis.

CCN proteins: multifunctional signalling regulators.

Transcriptional profiling of the scleroderma fibroblast reveals a potential role for connective tissue growth factor (CTGF) in pathological fibrosis.

P2888

s12079-010-0092-0

P304

155-156

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12079-010-0092-0

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2010-06-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47729915

http://www.w3.org/2001/XMLSchema#string

P698

21063505

http://www.w3.org/2001/XMLSchema#string

P932

2948118

http://www.w3.org/2001/XMLSchema#string